Simultaneous determination of omeprazole and domperidone in capsules and in vitro dissolution studies by using stability indicating UPLC

Journal of Liquid Chromatography and Related Technologies

Volumn 35, Issue 16, 2012, Pages 2322-2332

  Venkata Rao, P V ^a,b   Sanjeeva Reddy, Ch K ^a   Ravi Kumar, M ^a   Rao, Dantu Durga ^a,b  

^a DR REDDY'S LABORATORIES LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

domperidone; omperazole; stability indicating; UPLC

Indexed keywords

ACQUITY; ACQUITY UPLC SYSTEMS; COLUMN TEMPERATURE; DOMPERIDONE; FORCED DEGRADATION; IN-VITRO DISSOLUTION; ISOCRATIC ELUTION; MOBILE PHASE; OMEPRAZOLE; OMPERAZOLE; PHOSPHATE BUFFERS; RUNTIMES; SIMULTANEOUS DETERMINATIONS; UPLC;

ACETONITRILE; DISSOLUTION;

STABILITY;

ACETONITRILE; DOMPERIDONE; OMEPRAZOLE; PHOSPHATE BUFFERED SALINE;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); DEGRADATION; DRUG CAPSULE; DRUG FORMULATION; DRUG IMPURITY; DRUG SOLUBILITY; DRUG STABILITY; ELUTION; FLOW RATE; IN VITRO STUDY; PARTICLE SIZE; PH; TEMPERATURE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

EID: 84867364577     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826076.2011.631262     Document Type: Article

References (11)

1. Maton, P. N. N. Engl. J. Med., 1991, 324, 965.
2. Budavari, S. The Merck Index, 13th Ed.; Merck & Co: Whitehouse Station, NJ, 2001, 3476.
3. Wren, S.; Tchelitcheff, P. J. Chromatogr. A 2006, 1119, 140-146.
4. Novakova, L.; Matysova, L.; Solich, P. Talanta 2006, 68, 908-918.
5. Zarapkar, S. S.; Kanyawar, N. S. Simultaneous Estimation of Domperidone and Omeprazole in Pharmaceutical Dosage by Reverse Phase High-Performance Liquid Chromatography. Indian Drugs 2002, 39 (4), 217-221. (Pubitemid 34873761)
6. Patel, B.; Patel, M.; Patel, J. Simultaneous Determination of Omeprazole and Domperidone in Capsules by RP-HPLC and Densitometric HPTLC. J. Liq. Chromatogr. R. T. 2007, 30, 1749-1762. (Pubitemid 46718110)
7. Guidelines for Submitting Samples and Analytical Data for Methods Validation U.S.FDA. (Center for Drug Evaluation and Research) Feb.1987, U.S.G.P. O: 1990, 281-794, 20818.
8. USP 32, NF 27. The United State Pharmacopoeia; The National Formulary US Pharmacopoeia Convention, Rockyvilley, 2009.
9. ICH (International Conference on Harmonization)-Guidelines Q2A, Validation of Analytical Procedures: Definition and Terminology (CPMP III=5626=94) March (1995) Geneva, Switzerland.
10. ICH. (International Conference on Harmonization)-Guidelines Q2B, Validation of Analytical Procedures: Methodology (CPMP=ICH=281=95), IFPMA: Geneva, November, 1996.
11. ICH, Stability Testing of New Drug Substances and Products (Q1AR2). International Conference on Harmonization; IFPMA: Geneva, 2003.